64.49
price up icon1.78%   1.13
after-market Handel nachbörslich: 64.49
loading

Finanzdaten der Ptc Therapeutics Inc-Aktie (PTCT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-09-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
21.96%
164.68
211.01 178.88 1,176.10 196.79
Operating Expenses
13.48%
236.03
207.99 213.83 205.87 251.30
Benefits Costs and Expenses
29.77%
303.76
234.08 249.93 246.27 294.78
Costs And Expenses
29.77%
303.76
234.08 249.93 246.27 294.78
Operating Income/Loss
2,466%
-71.35
3.016 -34.96 970.23 -54.51
Income/Loss From Continuing Operations Before Tax
502.77%
-139.08
-23.07 -71.05 929.83 -97.99
Income Tax Expense/Benefit, Deferred
0.001
- - 0.002 -0.003
Income Tax Expense/Benefit
89.43%
-4.118
-38.97 -6.203 63.27 8.663
Income/Loss From Continuing Operations After Tax
949.05%
-134.97
15.90 -64.85 866.56 -106.65
Net Income/Loss
949.05%
-134.97
15.90 -64.85 866.56 -106.65
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
98.86%
0.8918
78.47 78.15 78.12 76.93
Diluted Average Shares
98.38%
1.4118
87.12 78.15 86.39 76.93
Basic Earnings Per Share
1,010%
-1.82
0.20 -0.83 11.09 -1.39
Diluted Earnings Per Share
935.00%
-1.67
0.20 -0.83 10.04 -1.39
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):